Description:

ODM derived from http://clinicaltrials.gov/show/NCT00273338

Link:

http://clinicaltrials.gov/show/NCT00273338

  1. 2/27/12 2/27/12 -
  2. 4/13/14 4/13/14 - Julian Varghese
Uploaded on:

April 13, 2014

DOI:
To request one please log in.
License :
Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility DRKS00003880 NCT00273338 Prostate Cancer

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Age >= 18 years
Histopathologically or cytologically proven adenocarcinoma of the prostate
Documented metastatic prostate adenocarcinoma
Documented progression while on androgen ablation therapy detected by rising prostate specific antigen (PSA) and/or imaging
Eastern Cooperative Oncology Group (ECOG) performance status <= 2
Adequate hematologic, renal and hepatic function
Life expectancy >= 3 months
Exclusion Criteria
Prior chemotherapy, except estramustine
Prior chemotherapy with docetaxel
Prior isotope therapy (e.g., strontium-89, samarium-153, etc.)
One or more contraindications to the use of corticosteroids
History of cancer-related hypercalcemia
Medical Concepts

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial